semaglutide diabetes trial Positive results in testing #GLP-1 targeting #diabetes/#weight-loss medicine (Ozempic, Wegovy) in treatment-seeking patents with #alcohol use disorder (AUD) who were also obese. Alcohol consumed dropped over 70% after 26 weeks A 72-week trial compared the

Protein content was determined using Pierce BCA Protein Assay kit (Thermo Fisher Scientific)

These products are not FDA-approved, have not been reviewed by FDA for safety and effectiveness, and FDA cautions they can lead to serious and potentially life-threatening adverse health consequences including infections and sepsis. Knock-off versions of semaglutide pose significant threats to peoples health and safety, a Novo Nordisk spokesperson said in an email to Healio | Endocrine Today

While some combinations may be beneficial, others might require adjustments to avoid exacerbating symptoms or adverse effects

& Vinggaard, A

This solution delivers more than appetite reduction

But yet, pharma is the most hated industry in America